Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 616-436-5 | CAS number: 77098-07-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics, other
- Type of information:
- other:
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: toxicokinetic statement
- Justification for type of information:
- REACH requires a theoretical assessment of the toxicokinetic behavoir of the substance.
Data source
Materials and methods
- Objective of study:
- other: toxicokinetic assessment
Test guideline
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- ADME assessment based on available physical chemical, structural and toxicological information.
- GLP compliance:
- no
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Absorption: The components with molecular weights of > 1000 and a high molecular volume are unlikely to be taken up after oral or dermal administration. Due to the highly viscous nature of the substance inhalation exposure is highly unlikely.
The lower molecular weight products had modelled log Kow values between 3.8 and 4.1 and are likely to be absorbed in the gastrointestinal tract. Dermal toxiicty of lower molecular weight analogs is very low and dose not indicate cosniderable absortption. - Details on distribution in tissues:
- After oral absorption the lower molecular weight components are likely metabolised in the liver by esterases yielding propyleneglycol and diethyeleneglycol which are further metaolised and excreted and 1,2-Benzene dicarboxylic acid, 3,4,5,6-tetrabromo. The acid may undergo glucuronidation or sulfatation to more hydrophilic components that are likely to be excreted via the urine or the gut. Oxidative metabiolism in the form of oxidative decarboxylation could also occur, but is less likely. Therefore the distribution of the parent will be relatively limited and an accumulation in fat tissue or othr tissues is not expected.
- Details on excretion:
- After oral absorption the lower molecular weight components are likely metabolised in the liver by esterases yielding propyleneglycol and diethyeleneglycol which are further metaolised and excreted and 1,2-Benzene dicarboxylic acid, 3,4,5,6-tetrabromo. The acid may undergo glucuronidation or sulfatation to more hydrophilic components that are likely to be excreted via the urine or the gut. Oxidative metabiolism in the form of oxidative decarboxylation could also occur, but is less likely.
Metabolite characterisation studies
- Details on metabolites:
- After oral absorption the lower molecular weight components are likely metabolised in the liver by esterases yielding propyleneglycol and diethyeleneglycol which are further metaolised and excreted and 1,2-Benzene dicarboxylic acid, 3,4,5,6-tetrabromo. Propyleneglycol and diethyeleneglycol are likely further metaolised and rapidly excreted. The acid may undergo glucuronidation or sulfatation to more hydrophilic components that are likely to be excreted via the urine or the gut. Oxidative metabiolism in the form of oxidative decarboxylation could also occur, but is less likely.
Applicant's summary and conclusion
- Conclusions:
- Only the lower molecualr weight parts of the UVCB substance are likely to be absorbed in particular when dosed via the oral route. Inhalation exposure is unlikely dur to the highly viscous character of the substance. Given the low dermal toxicity of lower molecular weight analogs dermal absorption is considered negligible. The lower molecula weight one ring components with predicted log Kow values between 3.8 and 4.1 can be absorbed and distributed. They are likely to undergo ester hydrolysis in the liver and potetially blood and other organs as esterases are occuring in many tissues. Primary metabolites after ester bond cleavage are propyleneglycol, diethyleneglycol and 1,2-Benzene dicarboxylic acid, 3,4,5,6-tetrabromo. Propyleneglycol and diethyeleneglycol are likely further metabolised and rapidly excreted. The acid may undergo glucuronidation or sulfatation to more hydrophilic components that are likely to be excreted via the urine or the gut. Oxidative metabiolism in the form of oxidative decarboxylation could also occur, but is less likely. In conclusion it is anticipated that the lowe molecular weight fractions of the UVCB can be taken up to a certain extedn in particular via the GI-tract and are likely rapidly metabolised. The metabolites are expected to be rapidly excreted.
- Executive summary:
Only the lower molecualr weight parts of the UVCB substance are likely to be absorbed in particular when dosed via the oral route. Inhalation exposure is unlikely dur to the highly viscous character of the substance. Given the low dermal toxicity of lower molecular weight analogs dermal absorption is considered negligible. The lower molecula weight one ring components with predicted log Kow values between 3.8 and 4.1 can be absorbed and distributed. They are likely to undergo ester hydrolysis in the liver and potetially blood and other organs as esterases are occuring in many tissues. Primary metabolites after ester bond cleavage are propyleneglycol, diethyleneglycol and 1,2-Benzene dicarboxylic acid, 3,4,5,6-tetrabromo. Propyleneglycol and diethyeleneglycol are likely further metabolised and rapidly excreted. The acid may undergo glucuronidation or sulfatation to more hydrophilic components that are likely to be excreted via the urine or the gut. Oxidative metabiolism in the form of oxidative decarboxylation could also occur, but is less likely. In conclusion it is anticipated that the lowe molecular weight fractions of the UVCB can be taken up to a certain extedn in particular via the GI-tract and are likely rapidly metabolised. The metabolites are expected to be rapidly excreted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.